Afferent is a leader in developing therapeutic candidates to treat common, poorly managed neurogenic conditions by targeting the P2X3 receptor, and its lead candidate, AF-219, is currently being evaluated in clinical trials to treat refractory, chronic cough, as well as idiopathic pulmonary fibrosis with cough.
The company’s adjusted earnings before interest, taxes, depreciation and amortization grew 35% to $15.7 million and its gross profit increased 3.1% to $141.3 million, compared to 137.1 million in the prior-year period.
Kmart parent company Sears Holdings on Thursday announced its first quarter sales figures, as well as the departure of its CFO and plans to explore ways to expand distribution of its key brands outside its own stores.
CVS Health’s efforts to dispense opioid overdose reversal drug naloxone without a prescription has already come to 23 states and the company has announced plans to expand to seven more over the course of the summer.
Excluding the negative impacts from gasoline prices deflation and foreign exchange, Costco's U.S. store base realized a 2% gain in same-stores sales in that four-week period and Costco's Canadian operation realized a 7% gain.
The deal will see the nation’s largest independent specialty pharmacy acquiring the seven-year-old oncology-focused company for $75 million, a mixture of cash and about 328,000 shares of Diplomat stock.